IL2 and neoplasm: In addition, celastrol directly binds to IL-2, disrupts the binding of IL-2 and CD25, markedly inhibits the proliferation and signaling of IL-2-dependent mouse T cells, and increases the number of CD8+ T cells, thereby inhibiting tumor growth.